Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Oriol Juanola, Sebastián Martínez‐López, Rubén Francés, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Zobair M. Younossi, Pegah Golabi, James M. Paik, et al.
Hepatology (2023) Vol. 77, Iss. 4, pp. 1335-1347
Open Access | Times Cited: 1412
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
James M. Paik, Linda Henry, Youssef Younossi, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 82
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Tingying Jiao, Yuandi Ma, Xiaozhen Guo, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1103-1119
Open Access | Times Cited: 77
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 35
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 22
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation
Gaolong Zuo, Meiyan Chen, Yingpeng Zuo, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 20
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada El‐Shabrawi, Louise A. Baur, et al.
Med (2024) Vol. 5, Iss. 7, pp. 797-815.e2
Closed Access | Times Cited: 20
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Alfredo Smiriglia, Nicla Lorito, Marina Bacci, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis: A cohort study
Furong Li, Jian Liao, Bin Zhu, et al.
Liver International (2022) Vol. 43, Iss. 2, pp. 299-307
Closed Access | Times Cited: 48
Analysis of environmental chemical mixtures and nonalcoholic fatty liver disease: NHANES 1999–2014
Wei Li, Haitao Xiao, Hong Wu, et al.
Environmental Pollution (2022) Vol. 311, pp. 119915-119915
Closed Access | Times Cited: 42
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies
Yujiao Zeng, Yuting Luo, Lijie Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3323-3323
Open Access | Times Cited: 38
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Tingli Guo, Wenhui Yan, Xin Cui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 33
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 12
Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10
A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 9
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Ziwei Guo, Qinjuan Wu, Pengfei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Fruit and vegetable intake and the risk of non-alcoholic fatty liver disease: a meta-analysis of observational studies
Rui Wang, Ruijuan Yan, Junzhe Jiao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 8
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 83-83
Open Access | Times Cited: 1
Bisphenol S accelerates the progression of high fat diet-induced NAFLD by triggering ferroptosis via regulating HMGCS2
Chunfeng Xie, Xinyao Jiang, Juan Yin, et al.
Journal of Hazardous Materials (2025) Vol. 487, pp. 137166-137166
Closed Access | Times Cited: 1
The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019
Huilong Chen, Yuan Zhan, Jinxiang Zhang, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 12, pp. e34809-e34809
Open Access | Times Cited: 32
Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
Teresa Auguet, Laia Bertran, Andrea Barrientos‐Riosalido, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13495-13495
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top